3 New Strong Buy Ratings from Top-Rated Analysts: 10/13/2026

By Jessie Moore, Stock Researcher and Writer
October 13, 2026 6:42 AM UTC
3 New Strong Buy Ratings from Top-Rated Analysts: 10/13/2026

Here’s a peek at the latest picks from our Strong Buy Stocks from Top Wall Street Analysts screener:

  • Bioventus (BVS): Strategic review underway with 45% upside target
  • Digital Turbine (APPS): Two top-rated analysts just initiated Strong Buy
  • Nvidia (NVDA): Ten top-1% analysts see up to 70% upside

P.S. Get more alerts like this daily … Try WallStreetZen Premium.

 


A note from our sponsors...

Hoping to Retire Soon?

There's a 73-minute "trading window" that is commonly exploited by retirees and those hoping to retire sooner. It works best if you can make this trade at a very specific time of day. 

Click here to know when you should make this morning trade.


1. Bioventus (NASDAQ: BVS)

This medical device company is currently exploring strategic alternatives to maximize shareholder value, presenting a compelling catalyst as it demonstrated solid Q2 execution with revenue growth and continued positive momentum heading into the second half of 2026.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $13.07 — get current quote

Max 1-year forecast: $19.00

Why we're watching:

  • BVS has limited, but overall bullish, coverage among the analysts we track, with 2 Strong Buy and 1 Buy recommendations. See all recommendations here
  • For example, Canaccord Genuity researcher Caitlin Cronin (a top 19% rated analyst) recently maintained her Strong Buy recommendation with a price target 45% above current levels. 
  • Q2 earnings demonstrated execution strength: EPS of $0.22 beat estimates by 4.8% with 5% year-over-year growth, while revenue of $153.21M declined 1.16% against estimates but grew 3.73% YoY.
  • Despite this fact, the stock has dipped recently … leading to our Editor-in-Chief alerting BVS as his Stock of the Week, where he called it a “juice buy the dip opportunity.” Find out why.
  • Industry ranking context: BVS is currently the #1 highest-rated stock in the Medical Device industry, which has an Industry Rating of C.
  • Zen Ratings highlights: BVS earns an overall A rating, equal to a Strong Buy recommendation. Stocks in this topmost tier have historically delivered nearly 30% annual returns, soundly beating the S&P.
  • Component Grades: BVS excels with an A for Financials, reflecting strong operational efficiency and disciplined cash management, while maintaining solid Bs for Growth, Safety, and Value, positioning it well as the strategic review unfolds. See all 7 Component Grades here

2. Digital Turbine (NASDAQ: APPS)

With a return to profitability forecasted and strong analyst support from top-rated researchers, this media solutions company is positioned to capitalize on enhanced monetization strategies and expanding market presence in the mobile advertising technology sector.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $10.43 — get current quote

Max 1-year forecast: $16.00

Why we're watching:

  • APPS has solid, bullish coverage among the analysts we track, with 4 Strong Buy and 1 Buy recommendations. See all recommendations here
  • For example, Benchmark researcher Daniel Kurnos (a top 4% rated analyst) initiated coverage with a Strong Buy recommendation and a price target over 40% above current levels. 
  • Coverage is ramping up … Roth Capital researcher Rohit Kulkarni (a top 3% rated analyst) recently initiated coverage with a Strong Buy recommendation and a price target well above current levels. 
  • Industry ranking context: APPS is currently the #6 highest-rated stock in the App industry, which has an Industry Rating of B.
  • Zen Ratings highlights: APPS earns an overall A rating, which amounts to a Strong Buy recommendation. This rating identifies stocks in the elite top 5% of all 4,600+ stocks tracked based on a rigorous 115-factor fundamental review.
  • Component Grades: APPS stands out with an A for Sentiment, reflecting strong analyst conviction on the turnaround story, alongside a solid B for Growth as the company pivots toward profitability and revenue expansion. See all 7 Component Grades here

3. Nvidia (NASDAQ: NVDA)

With dominant positioning in AI and data center infrastructure, the tech titan continues to extend its growth runway through technological innovation and expanding partnerships across gaming, automotive, and enterprise computing segments.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $229.28 — get current quote

Max 1-year forecast: $515.00

Why we're watching: 

  • NVDA has exceptionally broad, bullish coverage among the analysts we track, with 20 Strong Buy and 10 Buy recommendations. See all recommendations here
  • Cantor Fitzgerald researcher C.J. Muse (a top 1% rated analyst) recently reiterated his Strong Buy recommendation with a price target over 50% above current levels. 
  • Even better, Rosenblatt researcher Kevin Cassidy (a top 1% rated analyst) recently maintained his Strong Buy recommendation with a price target roughly 70% above current levels.
  • Eight additional analysts ranked in the top 1% of our system for stock-picking prowess maintain bullish outlooks on the semiconductor leader's AI growth trajectory.
  • Industry ranking context: NVDA is currently the #4 highest-rated stock in the Semiconductor industry, which has an Industry Rating of A.
  • Zen Ratings highlights: NVDA earns an overall A rating, which is equal to a Strong Buy recommendation. Stocks with this rating have historically delivered nearly 30% annual returns, consistently outperforming the broader market.
  • Component Grades: NVDA excels with an A for Financials, reflecting its fortress balance sheet and market leadership, while maintaining strong Bs for Sentiment and Momentum, a powerful combination for sustained appreciation in the AI era. See all 7 Component Grades here

What to Do Next?

Want to get in touch? Email us at news@wallstreetzen.com.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.